Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCUT II: Steroids and Cross-linking for Bacterial Corneal Ulcers
NCT04097730Phase 3Completed
- Start
- Sep 2020
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of difluprednate, riboflavin in bacterial keratitis. Started Sep 2020; status: completed.
02
Drugs
difluprednateriboflavin
03
Conditions
bacterial keratitis
Beyond the preview
Go deeper on NCT04097730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04097730.